SCHEMBL30668159

SCHEMBL30668159

NS(=O)(=O)c1c[nH]c2cc3c(cc12)OCO3

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.53
CA2 P00918 2/20 0.49
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR1A P08908 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR1E P28566 1/20 0.46
HTR1F P30939 1/20 0.46
HTR7 P34969 1/20 0.46
HTR2B P41595 1/20 0.46
HTR3A P46098 1/20 0.46
HTR5A P47898 1/20 0.46
HTR6 P50406 1/20 0.46
HTR4 Q13639 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30388511 0.84 KDM4E (0.53) KDM4ECA2HTR3EHTR3BHTR1A
SCHEMBL20354677 0.73 KDM4E (0.44) KDM4ECA2HTR3EHTR3BHTR1A
SCHEMBL29560048 0.73 KDM4E (0.44) KDM4ECA2HTR3EHTR3BHTR1A
SCHEMBL29162324 0.70 HTR3E (0.51) KDM4EHTR3EHTR3BHTR1AHTR1D
SCHEMBL18962466 0.70 HTR1D (0.55) KDM4EHTR3EHTR3BHTR1AHTR1D
SCHEMBL29561098 0.70 KDM4E (0.44) KDM4ECA2HTR1ATP53SMN1; SMN2
SCHEMBL20354834 0.70 POLB (0.45) KDM4EHTR1AHTR6ALDH1A1MAPT
SCHEMBL20355263 0.70 KDM4E (0.44) KDM4ECA2HTR1ATP53SMN1; SMN2
SCHEMBL2885649 0.70 HTR3E (0.48) KDM4EHTR3EHTR3BHTR1AHTR1D
SCHEMBL20355217 0.70 KDM4E (0.41) KDM4EHTR3EHTR3BHTR1AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2023-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 KDM4E 1609/4885CA2 3501/4885HTR3E 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.